| Dr Jessica Ann Knapp, DO | |
|
123 Hendersonville Rd, Asheville, NC 28803 | |
| (828) 257-4730 | |
| Not Available |
| Full Name | Dr Jessica Ann Knapp |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 14 Years |
| Location | 123 Hendersonville Rd, Asheville, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043539257 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mountain Area Health Education Center Inc | 0143206599 | 129 |
| Proactive Therapy Of North Carolina Inc | 6305753120 | 115 |
News Archive
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has cleared the Verax Platelet PGD® test as a quality control test to detect bacterial contamination in whole blood-derived, pooled platelets prior to transfusion. Fenwal is the exclusive global distributor of the test, which was developed by Verax Biomedical of Worcester, Mass.
Researchers at the University of California, Riverside have camels and llamas to thank for their development of a new cancer treatment that is highly selective in blocking the action of faulty matrix metalloproteinases (MMPs).
Our bodies have a variety of biological clocks that follow rhythms or oscillations with periods ranging from seconds to days. For example, our hearts beat every second, and cells divide periodically. The circadian clock located in the hypothalamus generates twenty-four hour rhythms, timing our sleep and hormone release.
DeCare Dental, a global dental benefit management company and a wholly owned subsidiary of Anthem Blue Cross and Blue Shield in Missouri's parent company, is pleased to introduce the International Emergency Dental Program – a service that gives dental members and their covered dependents access to emergency dental care from credentialed dentists around the world.
You can teach an old drug new chemotherapy tricks. Northwestern University researchers took a drug therapy proven for blood cancers but ineffective against solid tumors, packaged it with nanotechnology and got it to combat an aggressive type of breast cancer prevalent in young women, particularly young African-American women.
› Verified 9 days ago
| Entity Name | Mountain Area Health Education Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952356388 PECOS PAC ID: 0143206599 Enrollment ID: O20040625000988 |
News Archive
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has cleared the Verax Platelet PGD® test as a quality control test to detect bacterial contamination in whole blood-derived, pooled platelets prior to transfusion. Fenwal is the exclusive global distributor of the test, which was developed by Verax Biomedical of Worcester, Mass.
Researchers at the University of California, Riverside have camels and llamas to thank for their development of a new cancer treatment that is highly selective in blocking the action of faulty matrix metalloproteinases (MMPs).
Our bodies have a variety of biological clocks that follow rhythms or oscillations with periods ranging from seconds to days. For example, our hearts beat every second, and cells divide periodically. The circadian clock located in the hypothalamus generates twenty-four hour rhythms, timing our sleep and hormone release.
DeCare Dental, a global dental benefit management company and a wholly owned subsidiary of Anthem Blue Cross and Blue Shield in Missouri's parent company, is pleased to introduce the International Emergency Dental Program – a service that gives dental members and their covered dependents access to emergency dental care from credentialed dentists around the world.
You can teach an old drug new chemotherapy tricks. Northwestern University researchers took a drug therapy proven for blood cancers but ineffective against solid tumors, packaged it with nanotechnology and got it to combat an aggressive type of breast cancer prevalent in young women, particularly young African-American women.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jessica Ann Knapp, DO 119 Hendersonville Rd, Asheville, NC 28803-2868 Ph: (828) 257-4730 | Dr Jessica Ann Knapp, DO 123 Hendersonville Rd, Asheville, NC 28803 Ph: (828) 257-4730 |
News Archive
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has cleared the Verax Platelet PGD® test as a quality control test to detect bacterial contamination in whole blood-derived, pooled platelets prior to transfusion. Fenwal is the exclusive global distributor of the test, which was developed by Verax Biomedical of Worcester, Mass.
Researchers at the University of California, Riverside have camels and llamas to thank for their development of a new cancer treatment that is highly selective in blocking the action of faulty matrix metalloproteinases (MMPs).
Our bodies have a variety of biological clocks that follow rhythms or oscillations with periods ranging from seconds to days. For example, our hearts beat every second, and cells divide periodically. The circadian clock located in the hypothalamus generates twenty-four hour rhythms, timing our sleep and hormone release.
DeCare Dental, a global dental benefit management company and a wholly owned subsidiary of Anthem Blue Cross and Blue Shield in Missouri's parent company, is pleased to introduce the International Emergency Dental Program – a service that gives dental members and their covered dependents access to emergency dental care from credentialed dentists around the world.
You can teach an old drug new chemotherapy tricks. Northwestern University researchers took a drug therapy proven for blood cancers but ineffective against solid tumors, packaged it with nanotechnology and got it to combat an aggressive type of breast cancer prevalent in young women, particularly young African-American women.
› Verified 9 days ago
Caroline Knox, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 509 Biltmore Ave, Asheville, NC 28801 Phone: 828-213-4411 Fax: 866-285-9740 | |
John M. Lang, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Town Square Blvd, Suite 220, Asheville, NC 28803 Phone: 828-654-5012 Fax: 828-654-5014 | |
Katherine Danielle Lott, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Tunnel Rd, Asheville, NC 28805 Phone: 828-298-7911 | |
Dr. Dru Van Wilkes, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1100 Tunnel Rd, Asheville, NC 28805 Phone: 828-298-7911 Fax: 828-299-5854 | |
David A Wells, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1100 Tunnel Rd, Asheville, NC 28805 Phone: 828-298-7911 Fax: 828-299-5962 | |
Alan Sol Baumgarten, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 123 Hendersonville Rd, Asheville, NC 28803 Phone: 828-257-4730 | |
Karen Ledwith Dedman, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 90 Southside Ave, Suite 350, Asheville, NC 28801 Phone: 828-277-4810 |